FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 AG CARD

MDR report key: 14137899 · Received April 18, 2022

Report

Report Number
1221359-2022-02093
Event Type
Malfunction
Date Received
April 18, 2022
Date of Event
February 7, 2022
Report Date
April 18, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
10811877011290
PMA / PMN Number
EUA202537
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION REPORT: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. PERFORMED REVIEW OF MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING FOR KIT PART NUMBER 195-000 / LOT 157009R AND DEVICE PART NUMBER 195-430H / LOT 148391R. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH, INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE. RELATED MFR REPORT NUMBERS: 1221359-2022-02077 THROUGH 1221359-2022-02103.

Description of Event or Problem · 0

CUSTOMER REPORTED TWENTY-SEVEN (27) FALSE POSITIVE RESULTS WITH THE BINAXNOW COVID-19 AG CARD ON MULTIPLE DATES IN FEBURARY ON KITTED NASAL SWABS. THIS REPORT IS FOR PATIENT SEVENTEEN (17) OF TWENTY-SEVEN (27) AND LOT 157009 (TOTAL QUANTITY 3). PATIENT WAS TESTED WITH THE BINAXNOW COVID-19 AG CARD ON 07FEB2022 WHICH GENERATED A POSITIVE RESULT. CONFIRMATION PCR NASAL SAMPLE WAS COLLECTED THE SAME DAY, PLACED IN VTM, AND TRANSPORTED VIA CURRIER TO A SEPARATE BRANCH LAB FOR TESTING (PLATFORM: PERKINELMER) WHICH GENERATED A NEGATIVE RESULT. THE PATIENT WAS SYMPTOMATIC. NO SERIOUS INJURY, MEDICAL INTERVENTION OR TREATMENT DECISIONS OCCURRED AS A RESULT. CUSTOMER IS PERFORMING TESTS IN COMMUNITY ORGANIZATIONS (COHORT 1: K-12 SCHOOLS INCLUDING FACULTY).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
657981 BINAXNOW COVID-19 AG CARD LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 157009 10811877011290

Patients

Seq Age Sex Outcome Treatment
1 11 YR Male